Research
QUIZ: WHICH CLINICAL TRIAL
TOOL IS RIGHT FOR YOU?
Clinical research is the final, critical stage of the long scientific path to improved
therapies and cures for Parkinson’s disease (PD). Yet according to National Institute of
Health data, 85 percent of all trials face significant delays, and 30 percent never get off
the ground, due to an ongoing lack of volunteers. Anyone, with or without PD, can take
part. Answer these simple questions and we’ll point you toward the right first step.
YES
HAVE YOU BEEN
GENETICALLY TESTED
AND DID THE TEST
REVEAL THAT YOU
CARRY A LRRK2 OR
GBA MUTATION?
Though relatively few cases
of Parkinson’s are believed
to result from genetic
mutations like LRRK2 and
GBA, genetic research
is vital to pinpointing
biological clues about PD
that could benefit everyone
with the disease.
YES
NO
The Parkinson’s Progression
Markers Initiative (PPMI) is
the Foundation’s landmark
study in search of a
Parkinson’s biomarker.
LEARN MORE AT
MICHAELJFOX.ORG/PPMI
DO YOU HAVE
PARKINSON’S
DISEASE?
NO
YES
ARE YOU OF
ASHKENAZI JEWISH
DESCENT?
Ashkenazim and certain other
ethnic groups are at increased
risk of Parkinson’s from
mutations in the LRRK2 or GBA
genes, as compared to the
general population.
YES
NO
Fox Trial Finder
is the “Match.com”
of clinical studies and will
connect you to trials that
are right for you.
SEARCH FOR
STUDIES NEAR YOU AT
FOXTRIALFINDER.ORG
2
The Fox Focus
ARE YOU OVER 45,
WITH A FIRST-DEGREE
RELATIVE (FATHER,
MOTHER, FULL SIBLING
OR CHILD) WHO HAS OR
HAD PARKINSON’S?
NO
OR
Fox Insight is a digital platform
and dynamic online clinical
study to leverage “patient
power” by building a large,
diverse cohort providing data
on the lived experience of
Parkinson’s disease.
ENROLL AT
FOXINSIGHT.ORG